ID Ventures — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Peptinovopeptinovo.comJun 2021

Peptinovo develops a patented drug delivery platform (PALM carrier technology) intended to improve the efficacy of approved chemotherapies for a range of solid tumors while reducing serious side effects.

BiotechHealthtechAnn Arbor, US

REYNOLD HOMAN(Executive Officer, Director)BILL ELLIOTT(Executive Officer)STEVE TOKAZ(Executive Officer, Director)

BoardDAVID ROMENESCO(Director)FRED BROWN(Director)

Co-investorsWMU Biosciences Research & Commercialization Center

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.